Literature DB >> 12188326

MRI monitoring of tumor response to a novel VEGF tyrosine kinase inhibitor in an experimental breast cancer model.

Karl Turetschek1, Anda Preda, Eugenia Floyd, David M Shames, Viktor Novikov, Timothy P L Roberts, Jeanette M Wood, Yanjun Fu, Wayne O Carter, Robert C Brasch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12188326     DOI: 10.1016/s1076-6332(03)80281-7

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


× No keyword cloud information.
  5 in total

Review 1.  Molecular imaging in drug discovery and development: potential and limitations of nonnuclear methods.

Authors:  Markus Rudin; Martin Rausch; Markus Stoeckli
Journal:  Mol Imaging Biol       Date:  2005 Jan-Feb       Impact factor: 3.488

2.  Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.

Authors:  Bénédicte F Jordan; Matthew Runquist; Natarajan Raghunand; Amanda Baker; Ryan Williams; Lynn Kirkpatrick; Garth Powis; Robert J Gillies
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

3.  Imaging of VEGF receptor kinase inhibitor-induced antiangiogenic effects in drug-resistant human adenocarcinoma model.

Authors:  Wilfried Reichardt; Dana Hu-Lowe; Denise Torres; Ralph Weissleder; Alexei Bogdanov
Journal:  Neoplasia       Date:  2005-09       Impact factor: 5.715

4.  In vivo monitoring of angiogenesis inhibitory treatment effects by dynamic contrast-enhanced computed tomography in a xenograft tumor model.

Authors:  Hans-Juergen Raatschen; Yanjun Fu; Robert C Brasch; Hubertus Pietsch; David M Shames; Benjamin M Yeh
Journal:  Invest Radiol       Date:  2009-05       Impact factor: 6.016

5.  Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.

Authors:  Hans-Juergen Raatschen; Gerhard H Simon; Yanjun Fu; Barbara Sennino; David M Shames; Michael F Wendland; Donald M McDonald; Robert C Brasch
Journal:  Radiology       Date:  2008-03-27       Impact factor: 11.105

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.